Australia to prescribe MDMA and psilocybin for PTSD and depression

A new study indicates that reductions in experiential avoidance play a significant role in the therapeutic effects of psilocybin-assisted therapy among depressed patients, leading to improvements in well-being and reductions in depression severity…

Spontaneous and deliberate creative cognition during and after psilocybin (2021)

Psychotherapy with Psilocybin for Depression: Systematic Review

Australia the First Nation to Approve the Legal Use of MDMA and Psilocybin

Psilocybin-enhanced group psychotherapy for depression shows promise in patients with cancer

The mechanism of psilocybin therapy: With psilocybin therapy, but not escitalopram, improvements in mental health outcomes (i.e., well-being, depression severity, suicidal ideation, and trait anxiety) occurred via reductions in experiential avoidance.

Patients tend to have a stronger brain response to music the day after receiving psilocybin-assisted therapy, according to new research

Preliminary study reveals potential of psilocybin for cluster headache treatment

A study of psilocybin reducing alcohol consumption in male mice was recently published in Frontiers in Pharmacology